Michael Schuster
Corporate Officer/Principal bij MESOBLAST LIMITED
Profiel
Michael Schuster was the founder of Mesoblast, Inc. (founded in 2001) where he held the title of Head-Business Development from 2001 to 2009.
He is also the founder of Mesoblast Ltd.
where he currently holds the title of Head-Pharma Partnering since 2004.
Additionally, Mr. Schuster has worked as the Head-Investor Relations at Angioblast Systems, Inc. Mr. Schuster's education includes an MBA from Fordham University, an undergraduate degree from Tufts University (conferred in 1999), and a graduate degree from New York Medical College.
Actieve functies van Michael Schuster
| Bedrijven | Functie | Begin |
|---|---|---|
| MESOBLAST LIMITED | Corporate Officer/Principal | 01-01-2004 |
Eerdere bekende functies van Michael Schuster
| Bedrijven | Functie | Einde |
|---|---|---|
| Angioblast Systems, Inc. | Investor Relations Contact | - |
Mesoblast, Inc.
 Mesoblast, Inc. Pharmaceuticals: MajorHealth Technology Mesoblast, Inc. manufactures and distributes biopharmaceutical products. It develops cellular medicines for under-served therapeutic areas including cardiac diseases, spine orthopedic disorders, oncology and hematology diseases, and immune-mediated and inflammatory conditions. The company was founded by Michael Schuster and Silviu Itescu in 2004 and is headquartered in New York, NY. | Founder | - |
Opleiding van Michael Schuster
| Fordham University | Masters Business Admin |
| Tufts University | Undergraduate Degree |
| New York Medical College | Graduate Degree |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Beursgenoteerde bedrijven | 1 |
|---|---|
| MESOBLAST LIMITED | Health Technology |
| Bedrijven in privébezit | 2 |
|---|---|
Mesoblast, Inc.
Mesoblast, Inc. Pharmaceuticals: MajorHealth Technology Mesoblast, Inc. manufactures and distributes biopharmaceutical products. It develops cellular medicines for under-served therapeutic areas including cardiac diseases, spine orthopedic disorders, oncology and hematology diseases, and immune-mediated and inflammatory conditions. The company was founded by Michael Schuster and Silviu Itescu in 2004 and is headquartered in New York, NY. | Health Technology |
| Angioblast Systems, Inc. |
